GlaxoSmithKline PLC

Healthcare · Drug Manufacturers - General

50.50$ +0.3% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Balance Sheet

GlaxoSmithKline PLC (GSK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 61,011 million GBP. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of GBP.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GSK
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	8,314	8,437	9,346	10,427	21,590	21,966	22,327	23,944	22,944	27,198	25,553	31,003	39,393	42,862	42,052	41,080	41,475	42,086	40,651	53,446	59,081	56,381	58,066	105,572	109,945	107,141	60,146	75,220	59,463	61,011
Current Assets	4,368	4,802	5,509	6,080	11,268	10,019	10,749	12,608	10,780	13,177	10,992	13,626	17,269	17,570	16,036	16,167	13,692	15,227	14,678	16,587	16,711	15,907	16,927	25,821	27,677	25,293	20,769	23,767	16,997	17,479
Cash	261	215	240	217	1,283	718	1,052	961	2,467	4,209	2,005	3,379	5,623	6,545	6,057	5,714	4,184	5,534	4,338	5,830	4,897	3,833	3,874	6,236	8,601	5,789	3,723	3,743	3,693	3,391
Cash & Short-Term Investments	1,262	1,662	1,885	1,966	3,592	2,321	2,469	3,451	3,979	5,234	3,040	5,010	6,870	6,942	6,334	5,898	4,265	5,600	4,407	5,905	4,986	3,911	3,958	6,340	8,707	5,872	7,877	6,606	3,714	3,400
Receivables	2,223	2,206	2,389	2,490	5,201	4,533	6,022	4,753	5,418	4,822	5,501	5,558	6,265	6,248	5,591	5,320	5,060	5,152	4,486	3,879	5,917	5,950	6,322	9,469	9,930	10,878	6,218	9,437	5,999	7,745
Inventory	804	855	1,154	1,537	2,277	2,094	2,080	2,106	2,193	2,177	2,437	3,062	4,056	4,064	3,837	3,873	3,969	3,900	4,231	4,716	5,102	5,557	5,476	7,878	8,196	7,833	5,146	7,009	5,669	5,914
Property, Plant & Equipment	–	–	–	–	9,933	9,955	10,702	11,492	12,398	11,433	13,573	15,519	14,148	15,155	13,922	13,592	14,272	14,704	14,101	9,668	10,808	10,860	11,058	11,314	11,006	10,672	9,620	9,957	10,073	10,048
Goodwill	–	–	–	–	254	253	18,160	143	26	696	758	1,370	2,101	3,361	3,606	3,754	4,359	4,205	3,724	5,162	5,965	5,734	5,789	13,992	14,486	14,292	7,046	8,683	6,982	7,006
Intangible Assets	2,223	2,206	106	144	1,136	1,851	1,808	1,695	2,817	3,383	3,293	4,456	5,869	8,183	8,469	7,802	10,161	9,283	8,320	16,672	18,776	17,562	17,202	41,008	40,768	40,741	14,318	18,826	15,515	16,719
Total Liabilities	7,047	6,547	6,578	7,234	12,635	13,568	14,939	15,490	17,007	19,628	15,905	21,093	31,075	32,120	32,307	32,253	34,728	34,274	35,715	44,568	54,118	52,892	54,394	81,254	81,502	78,234	50,050	58,909	46,377	45,016
Current Liabilities	4,154	3,886	4,145	5,263	9,084	9,451	8,808	8,585	8,718	9,511	7,265	10,345	10,017	12,118	12,616	15,010	13,815	13,677	13,295	13,417	19,001	26,569	22,491	31,860	30,275	32,060	22,810	26,857	21,697	21,353
Short-Term Debt	1,546	1,181	1,317	2,250	2,281	2,129	1,551	1,450	1,582	2,095	718	3,504	956	1,471	291	2,698	3,702	2,789	2,943	1,308	4,129	2,825	5,793	9,165	5,092	4,877	3,952	3,586	2,349	3,007
Accounts Payable	270	299	293	367	812	762	715	685	2,460	819	865	1,757	6,075	6,772	2,141	2,568	2,666	2,739	7,958	9,191	11,964	20,970	3,645	5,490	5,956	6,142	3,866	4,738	3,462	15,354
Long-Term Debt	–	–	–	–	2,619	3,066	4,977	6,514	8,394	9,060	9,346	14,023	22,266	23,905	22,794	18,960	23,858	25,617	24,677	15,277	14,620	14,221	20,227	22,580	23,425	20,572	17,035	14,154	13,703	14,015
Shareholders' Equity	1,225	1,843	2,702	3,142	7,711	7,533	6,581	7,710	5,724	7,311	9,386	9,603	7,931	10,005	8,887	8,032	5,810	6,997	4,936	8,878	4,963	3,489	3,781	15,109	19,940	20,391	10,598	17,015	13,671	16,348
Retained Earnings	–	–	–	–	4,276	3,947	2,946	4,039	4,542	5,579	6,965	6,475	4,622	6,321	4,779	3,370	652	913	-2,074	-1,397	-5,392	-6,477	-2,701	8,451	11,761	13,264	4,363	9,228	7,796	10,191
Shares Outstanding	2,819	2,882	2,909	2,911	2,454	2,448	2,374	2,315	2,294	2,292	2,283	2,227	2,090	2,043	2,051	2,040	1,996	1,968	1,946	1,955	1,964	1,976	1,988	2,006	2,015	1,621	2,042	2,056	2,071	2,059

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings